文献速递肾小球疾病

工程化抗原特异性Treg抑制抗GBM病自身反应

Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen.
PubMed 文献 · Kidney Int · 2025-01-20

抗GBM病伴随抗原特异性调节性T细胞(Treg)不足及抗原特异性传统T细胞克隆扩增,尤其针对IV型胶原α3(IV)NC1 135-145表位(由HLA-DRB1*1501呈递)。本研究构建表达GBM特异性T细胞受体(TCR)的Treg,发现其表型稳定、能产生抗原特异性功能反应,且比多克隆Treg或无关TCR转导Treg更优地抑制自身反应性及旁观者传统T细胞,并促使树突状细胞和B细胞向耐受表型转化,支持其作为抗GBM病细胞疗法的前景。

要点

  • GBM-TCR Treg表型稳定且具抗原特异性功能反应
  • GBM-TCR Treg抑制自身反应性及旁观者传统T细胞优于对照Treg
  • GBM-TCR Treg促使树突状细胞和B细胞向耐受表型转化

核心结论

  • GBM-TCR Tregs可作为抗GBM病有前景的细胞疗法进行开发。

研究设计与样本

  • 体外研究:构建表达针对α3(IV)NC1 135-145表位的GBM特异性TCR的Treg,并与多克隆Treg或无关TCR转导Treg比较。

主要发现

  • GBM-TCR Treg产品表型稳定,产生α3(IV)NC1 135-145特异性功能反应。
  • GBM-TCR Treg抑制自身反应性传统T细胞和旁观者传统T细胞优于多克隆Treg或无关TCR转导Treg。
  • GBM-TCR Treg调节树突状细胞和B细胞向更耐受的表型转化。

临床怎么用

  • 支持将GBM-TCR Treg作为抗GBM病的候选细胞疗法进一步开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Anti-glomerular basement membrane (anti-GBM) disease is accompanied by insufficient antigen-specific regulatory T cells (Tregs) and clonally expanded antigen-specific conventional T cells. In particular, this applied to the immunodominant T cell autoepitope of type IV collagen, α3(IV)NC1135-145, presented by human leukocyte antigen-DRB1∗1501. Here, we investigated whether Tregs engineered to express GBM-T cell receptors (TCR) specific for α3(IV)NC1135-145 better suppress autoimmunity. The GBM-TCR Treg cell product exhibited a phenotypically stable Treg phenotype, produced α3(IV)NC1135-145-specific functional responses, and were superior suppressors of autoreactive conventional T cells and bystander conventional T cells compared to polyclonal Tregs or irrelevant TCR-transduced Tregs. We also found that GBM-TCR Tregs modulate other immune cells like dendritic cells and B cells to a more tolerogenic phenotype. Importantly, our findings support the development of GBM-TCR Tregs as a promising cell-based therapy for anti-GBM disease.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Eggenhuizen PJ, Ng BH, Lo C, et al. Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen. Kidney Int. 2025. PMID: 39842638. doi:10.1016/j.kint.2025.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。